FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 107 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,448,000 | -5.2% | 108,726 | -0.7% | 0.01% | -14.3% |
| Q3 2016 | $5,746,000 | +27.8% | 109,459 | +0.7% | 0.01% | +16.7% |
| Q2 2016 | $4,495,000 | +34.2% | 108,709 | +31.9% | 0.01% | +50.0% |
| Q1 2016 | $3,350,000 | +3.9% | 82,443 | +6.1% | 0.00% | 0.0% |
| Q4 2015 | $3,225,000 | +176.3% | 77,722 | +2.5% | 0.00% | +100.0% |
| Q3 2015 | $1,167,000 | -38.3% | 75,843 | -0.4% | 0.00% | 0.0% |
| Q2 2015 | $1,891,000 | +40.1% | 76,126 | +28.8% | 0.00% | 0.0% |
| Q1 2015 | $1,350,000 | +0.4% | 59,102 | +18.7% | 0.00% | 0.0% |
| Q4 2014 | $1,344,000 | +128.6% | 49,779 | -0.6% | 0.00% | +100.0% |
| Q3 2014 | $588,000 | -23.1% | 50,098 | +1.9% | 0.00% | 0.0% |
| Q2 2014 | $765,000 | +100.8% | 49,174 | +153.4% | 0.00% | 0.0% |
| Q1 2014 | $381,000 | +77.2% | 19,404 | +51.8% | 0.00% | – |
| Q4 2013 | $215,000 | – | 12,786 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 115,500 | $2,531,000 | 0.89% |
| AWM Investment Company, Inc. | 150,000 | $3,288,000 | 0.64% |
| BB BIOTECH AG | 827,500 | $18,139,000 | 0.51% |
| Virtus ETF Advisers LLC | 17,371 | $381,000 | 0.48% |
| Rock Springs Capital Management LP | 425,000 | $9,316,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,728 | $9,880,000 | 0.39% |
| Telemetry Investments, L.L.C. | 44,176 | $968,000 | 0.37% |
| RTW INVESTMENTS, LP | 100,377 | $2,200,000 | 0.37% |
| Eventide Asset Management | 315,000 | $6,905,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 52,500 | $1,151,000 | 0.22% |